ストックスクリーナーアプリを入手
225.18
0.97%
2.19
アフターアワーズ：
225.34
0.16
+0.07%
Abbvie Inc (ABBV) 最新ニュース
ASH 2025: AbbVie and Genmab’s Epkinly sets new standard in second-line FL - Yahoo Finance
AbbVie upgraded, Biogen downgraded at HSBC (BIIB:NASDAQ) - Seeking Alpha
Crohn’s Disease Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes | AbbVie, Merck, Eli Lilly and Company, RedHill Biopharma, Bristol Myers Squibb, Dr. Falk Pharma GmbH - Barchart.com
Here Are Wednesday’s Top Wall Street Analyst Research Calls: AbbVie, Amazon.com, Biogen, EchoStar, Ferrari, GE Vernova, PepsiCo, Take-Two Interactive, and More - Yahoo Finance
AbbVie Stock (ABBV) Opinions on Analyst Upgrade and Pipeline Developments - Quiver Quantitative
Here Are Wednesday's Top Wall Street Analyst Research Calls: AbbVie, Amazon.com, Biogen, EchoStar, Ferrari, GE Vernova, PepsiCo, Take-Two Interactive, and More - 24/7 Wall St.
HSBC Upgrades AbbVie (ABBV) to Buy, Raises Price Target to $265 - GuruFocus
This AbbVie Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday - Benzinga
Analyst recommendations: Abbvie, Biogen, PepsiCo, Eli Lilly, Netflix… - marketscreener.com
HSBC Upgrades AbbVie to Buy From Hold, Adjusts Price Target to $265 From $225 - marketscreener.com
Investment Management Corp of Ontario Has $19.88 Million Position in AbbVie Inc. $ABBV - MarketBeat
iSAM Funds UK Ltd Takes $3.39 Million Position in AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Shares Bought by State Street Corp - MarketBeat
Daiwa Securities Group Inc. Buys 38,862 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie (ABBV) Falls More Steeply Than Broader Market: What Investors Need to Know - Yahoo Finance
AbbVie (NYSE:ABBV) Shares Down 1.4%Here's Why - MarketBeat
Genmab Announces New Data from Phase 1b/2 EPCORE® CLL-1 Highlighting Potential of Epcoritamab as Monotherapy and in Combination for Patients with Richter Transformation (RT) - GlobeNewswire Inc.
How Investors May Respond To AbbVie (ABBV) Expanding Its Pipeline With New Migraine And Oncology Data - Yahoo Finance
Why Investors Shouldn't Be Surprised By AbbVie Inc.'s (NYSE:ABBV) Low P/S - 富途牛牛
Ose Immunotherapeutics stock falls after AbbVie deal amendment By Investing.com - Investing.com UK
SVB Wealth LLC Sells 113,330 Shares of AbbVie Inc. $ABBV - MarketBeat
Ossiam Has $51.75 Million Holdings in AbbVie Inc. $ABBV - MarketBeat
Gabelli Funds LLC Cuts Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
Jump Financial LLC Buys New Shares in AbbVie Inc. $ABBV - MarketBeat
OSE Immunotherapeutics Amends Partnership With AbbVie for Inflammation Drug Development - marketscreener.com
OSE Immunotherapeutics Announces Strategic Amendment to AbbVie’s Partnership on ABBV-230 Development - Yahoo Finance
Ophthalmic Drugs Market Size to Cross USD 62.74 Billion by 2032, Driven by Advances in Eye Care Treatments and Rising Global Vision Disorders - GlobeNewswire Inc.
Federated Hermes Inc. Acquires 134,942 Shares of AbbVie Inc. $ABBV - MarketBeat
California Public Employees Retirement System Sells 778,732 Shares of AbbVie Inc. $ABBV - MarketBeat
Cerity Partners LLC Has $210.15 Million Holdings in AbbVie Inc. $ABBV - MarketBeat
Stenger Family Office LLC Takes Position in AbbVie Inc. $ABBV - MarketBeat
SCS Capital Management LLC Increases Stock Position in AbbVie Inc. $ABBV - MarketBeat
1832 Asset Management L.P. Increases Stock Position in AbbVie Inc. $ABBV - MarketBeat
AbbVie (NYSE:ABBV) Shares Down 1.1%What's Next? - MarketBeat
Mirabella Financial Services LLP Has $2.41 Million Position in AbbVie Inc. $ABBV - MarketBeat
Marshall Wace LLP Grows Stake in AbbVie Inc. $ABBV - MarketBeat
M Holdings Securities Inc. Increases Holdings in AbbVie Inc. $ABBV - MarketBeat
Quantbot Technologies LP Takes Position in AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Shares Bought by Brown Advisory Inc. - MarketBeat
Amundi Purchases 2,435,372 Shares of AbbVie Inc. $ABBV - MarketBeat
Arrowstreet Capital Limited Partnership Has $58.79 Million Stake in AbbVie Inc. $ABBV - MarketBeat
AbbVie-Sponsored Symposium at ESMO Asia 2025 Highlights Urgent Medical Need in Platinum-Resistant Advanced Ovarian Cancer - PR Newswire
Is AbbVie Inc. (4AB) stock undervalued after correctionWeekly Trade Summary & Community Consensus Picks - Newser
How Strong Is AbbVie's Immunology Franchise After Humira's LOE? - The Globe and Mail
Could buying AbbVie today set you up for life? - MSN
Could Buying AbbVie Today Set You Up for Life? - Nasdaq
Dry Eye Disease Treatment Market Outlook Report 2032 | Alcon - openPR.com
Kennedy Capital Management LLC Reduces Holdings in AbbVie Inc. $ABBV - MarketBeat
Why AbbVie Inc. stock attracts global investorsMarket Performance Summary & Fast Exit and Entry Strategy Plans - Newser
First Trust Advisors LP Trims Stake in AbbVie Inc. $ABBV - MarketBeat
AbbVie (ABBV) Stock in December 2025: Atogepant Breakthrough, Q3 Beat and 2026 Outlook After Medicare Price Cuts - ts2.tech
Baird Financial Group Inc. Sells 36,202 Shares of AbbVie Inc. $ABBV - MarketBeat
Assessing AbbVie’s (ABBV) Valuation After New Cancer Data, EPKINLY Approval, and Dividend Hike - simplywall.st
AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Dermal Fillers Market Size Report 2032 | AbbVie Inc., Galderma, - openPR.com
AbbVie looks to expand use cases for migraine drug after promising study - Crain's Chicago Business
Invesco Ltd. Lowers Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Shares Bought by CW Advisors LLC - MarketBeat
Is AbbVie Inc. stock undervalued at current priceSwing Trade & Weekly High Conviction Ideas - Newser
Is It Too Late to Consider AbbVie After Its Strong Multi Year Share Price Rally? - Yahoo Finance
AbbVie (ABBV) Stock on December 2, 2025: Dividend Hike, Cancer Pipeline Momentum and 2026 Outlook - ts2.tech
Metastatic Non-Small Cell Lung Cancer Market on Track for Major Expansion by 2034, According to DelveInsight | AbbVie, Xcovery, Sanofi, NeoImmune Tech, Merck KGaA and Pfizer, Mirati Therapeutics - Barchart.com
AbbVie (NYSE:ABBV) Is Increasing Its Dividend To $1.73 - simplywall.st
AbbVie to feature new data at ASH 2025 - MarketScreener
AbbVie to Feature New Data at ASH 2025 Showcasing Continued Advances Across Novel Treatment Modalities in Multiple Blood Cancers - Investing News Network
Isthmus Partners LLC Raises Stake in AbbVie Inc. $ABBV - MarketBeat
2 Top Dividend Stocks to Buy Now and Hold For a Decade - AOL.com
Portfolio Design Labs LLC Has $571,000 Stake in AbbVie Inc. $ABBV - MarketBeat
Shelton Capital Management Has $7.29 Million Stake in AbbVie Inc. $ABBV - MarketBeat
Panagora Asset Management Inc. Reduces Stock Position in AbbVie Inc. $ABBV - MarketBeat
Loomis Sayles & Co. L P Purchases 18,866 Shares of AbbVie Inc. $ABBV - MarketBeat
3.28%
大文字化:
|
ボリューム (24 時間):